Given the complex pathogenesis of HCC, various diagnostic modalities are currently employed for HCC, including blood-based tumor markers such as alpha-fetoprotein (AFP) and circulating tumor DNA (ctDNA) analysis, as well as imaging techniques like ultrasound and PET/CT [5,6]. This evidence concerns the gene AFP and neoplasm.